Recommend Limiting Dose and Duration of NSAIDs in High-CV-Risk Patients

Controversy will continue to brew over the safety of NSAIDs in patients at high cardiovascular risk....

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote